Further investigation into the mechanism of conformational activation may provide new insights into these physiological processes and may be an important consideration as ADAMTS13, particularly conformationally activated variants, are developed as potential therapeutic agents for the treatment of ischemic stroke and other cardiovascular diseases. This evidence concerns the gene ADAMTS13 and ischemic stroke.